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SUMMARY 
The immunosuppression in dengue type 2 virus (DV)-infected mice is mediated 
through secretion of a soluble suppressor factor (SF) produced by the T lymphocytes 
of the spleen. Activity of the suppressor cells was abrogated by pretreatment with 
indomethacin, indicating thatsuppression is mediated through prostaglandin (PG) or 
products of the PG synthetase pathway. The present study was undertaken to 
resolve the relationship between SF and PG. Treatment of mice with indomethacin 
did not affect production of SF. Therefore, PG is different from SF and the presence 
of PG is not essential for its production. Normal mouse spleen cells treated in vitro 
with SF produced PG which mediated suppression. Pr duction of PG by these cells 
was abolished by pretreatment with anti-Thy 1.2 antibody and complement. It is 
concluded, therefore, that immunosuppression occurs in two phases: in the first step 
DV stimulates a subpopulation of T lymphocytes toproduce SF, and in the second 
step SF induces a subpopulation of T lymphocytes to produce PG or products of the 
PG synthetase pathway which finally mediate suppression. 
INTRODUCTION 
Infection by a number of viruses is associated with immunosuppression in the host, but the 
mechanism ofimmunosuppression s ot well understood (Woodruff & Woodruff, 1975). The 
immunosuppression observed in dengue type 2 virus (DV)-infected mice (Chaturvedi et al., 
1977, 1978a) appears to be mediated by two factors, the cytotoxic factor (CF) and the 
suppressor factor (SF), both being produced in the spleen by T lymphocytes (Chaturvedi et 
al., 1980a; Tandon et al., 1979b). CF is a protein which destroys macrophages and a 
subpopulation of T lymphocytes, thus mediating immunosuppression non-specifically, and is 
effective against unrelated antigens like sheep red blood cells (SRBC) (Chaturvedi et al., 
1980b, 1981b). The suppressor T lymphocytes induced in DV-primed mice (Tandon et al., 
1979a) mediate suppression thr ugh a soluble substance, theSF (Chaturvedi & Shukla, 
1981). We have purified and characterized the SF. It is a highly potent, heat-labile, 
trypsin-resistant, unstable t acid and alkaline pH, dialysable, low mol. wt. substance 
(Chaturvedi & Shukla, 1981). We have also observed that pretreatment of the suppressor 
cells with indomethacin or aspirin, the well known inhibitors of prostaglandin synthetase 
(Vane, 1976), abolishes the suppressor activity of the cells, thus showing that suppression 
may be mediated through prostaglandin (Chaturvedi et al., 1981 a). We know of no previous 
similar study in virus infections. While further exploring the nature of SF a number of 
possibilities were taken into account, namely, SF is a prostaglandin (PG) produced by T cells 
on stimulation by DV; or SF is an intermediate product and stimulates the production of PG 
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which ultimately results in immunosuppression; or DV stimulates the T lymphocytes to 
produce PG which induces a suppressor cell to produce the soluble SF, To examine these 
questions, experiments were done both in vitro and in vivo. Findings of the present study 
demonstrate hat DV induces T cells to produce SF which in turn, induces production of PG 
which mediates immunosuppression. 
METHODS 
Animals. Inbred adult Swiss albino mice aged 4 to 6 months obtained from the colony of 
this department were used. 
Virus. The details of the dengue type 2 virus (DV) strain 23085 and the experimental 
model have been described elsewhere (Chaturvedi et al., 1977, 1978 a; Agrawal et al., 1978). 
Throughout this study a dose of 1000 LDs0 of the DV has been used. The other antigens used 
in specificity experiments were Japanese ncephalitis virus (JEV) strain 78668A (Mathur et 
al., 1981) used as mouse brain suspension; Coxsackie B4 virus (Cox. B4) used as monkey 
kidney tissue culture fluid (Chaturvedi et al., 1978 b); and SRBC kept in Alsever's olution 
and washed three times before use (Chaturvedi et al., 1981 b). The doses of the viruses were 
1000 LDso (JEV) or 1000 TCIDs0 (Cox. B4) and that of SRBC was 108 cells/culture. 
Preparation of suppressor cells and suppressor factor. Suppressor cells develop in the 
spleen of mice infected intracerebrally with DV 8 to 11 days post-infection (Tandon et al., 
1979 a, b). Therefore, spleens were collected from the moribund mice at the above periods and 
a single cell suspension was prepared and used as suppressor cells. The details of the 
preparation of SF have been described previously (Chaturvedi & Shukla, 1981). Briefly, 
spleens collected from the virus-infected moribund mice on 8 to 11 days post-infection were 
homogenized in chilled phosphate-buffered saline (PBS) pH 7. The homogenate was 
centrifuged in the cold at 2000 g for 10 min and then at 103 500 g for 3 h. The supernate was 
collected, divided into small aliquots and stored at -20  °C and used as suppressor factor 
(SF). 
Preparation of spleen cells. The spleen cells were teased out in chilled minimum essential 
medium (MEM) with 10% foetal calf serum (Armour Pharmaceutical, Eastbourne, Sussex, 
U.K.). A single cell suspension was prepared and the viable nucleated cells were counted 
using trypan blue dye exclusion (Chaturvedi et aL, 1978 b). 
Preparation of enriched spleen cell populations. The procedures of cell enrichment have 
been described previously (Tandon et al., 1979b; Chaturvedi et al., 1979, 1980a). Briefly, the 
macrophages were depleted by treating the spleen cell suspension with carbonyl iron 
(Lymphocyte Separator Reagent, Technicon Instruments, N.Y., U.S.A.) and a magnet. The T 
and B lymphocytes were separated by filtration of macrophage-depleted spleen cells through 
nylon-wool columns (Julius et al., 1973). Glass-adherent and non-glass-adherent cells were 
separated as described earlier (Chaturvedi et al., 1978b) by incubating whole spleen cell 
suspension i Petri dishes at 37 °C in the presence of 5 % CO 2. 
Preparation of spleen cell cultures. Normal mouse spleen cells were cultured in 5 cm glass 
Petri dishes. Each Petri dish was seeded with 4 ml cell suspension (4 × 106 cells/ml) prepared 
in MEM-HEPES containing 10% foetal calf serum and 5 × 10 -5 M-2 mercaptoethanol. The 
cultures were incubated at 37 °C in an atmosphere of 5 % CO 2. 
Drug treatment. Indomethacin (Sigma) was used to inhibit production of PG. The drug 
was dissolved in 0.85% NaC1 containing 1% sodium bicarbonate (Lapp et al., 1980). 
Further dilutions of the drug were prepared in MEM. The cells were treated with 10 -6 M of 
the drug at 37 °C for 1 h (Mattingly & Kemp, 1979) and washed three times. The drug 
treatment had no effect on the viability of the cells. The production of PG in mice was 
inhibited by administration of0.3 mg of the drug intraperitoneally (i.p.) 24 and 2 h before the 
virus and then 0.1 mg i.p. at 48 h intervals. 
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Treatment with anti-thymocyte s rum. To kill T lymphocytes the spleen cell suspension 
was treated with monoclonal anti Thy 1.2 antibody (New England Nuclear) and 
complement by the technique of Golub (1971) as described elsewhere (Tandon et al., 1979 a). 
Serum, complement and cell controls were included with every test. 
Detection of antibody-forming cells. The direct immunoglobulin M plaque-forming cells 
(PFC) against DV were counted by the localized haemolysis in gel technique of Jerne & 
Nordin (1963). The details of the technique have b en described earlier (Chaturvedi et al., 
1977; Tandon & Chaturvedi, 1977). 
Experimental protocol. The experimental protocol was similar to that described earlier 
(Tandon et al., 1979 a, b; Chaturvedi et al., 1981 a; Chaturvedi & Shukla, 1981). Briefly, the 
suppressor activity of the preparation was studied using PFC against DV in the spleens of 
mice or in spleen cell cultures as indicator systems. For in vivo study, mice were given 1000 
LDso DV i.p. followed 48 h later by intravenous (i.v.) injection of 0.25 ml SF (1:100 
dilution). For in vitro study, normal mouse spleen cell cultures were prepared and inoculated 
with 1000 LDs0 DV at 0 h followed 24 h later by inoculation of 0.25 ml SF (1 : 100 dilution). 
The peak PFC response occurs on the sixth and seventh days after i.p. inoculation of mice 
with DV (Chaturvedi et al., 1977, 1981a; Tandon & Chaturvedi, 1977). In the spleen cell 
cultures the peak PFC response was observed on days 3 and 4 after DV inoculation (U. C. 
Chaturvedi et al., unpublished observations). In the present study, therefore, observations 
were recorded on these days. Each in vitro experiment was set up in triplicate and was 
repeated two or three times. For in vivo experiments, five to eight mice were used in each 
group of replicate xperiments. From each mouse or culture multiple slides were prepared. 
The PFC count on the 2 days of the experiment (6 and 7 days in vivo and 3 and 4 days in 
vitro) were similar and therefore the values have been pooled for ease of presentation. Mean 
values with standard eviation have been presented after deducting background PFC. The 
data have been analysed by Student's t-test for P-values. 
RESULTS 
Production of SF by T lymphocytes 
To study the splenic cell type responsible for production of SF the cell populations were 
enriched and homogenized. The suppressor activity of the cell homogenate was screened in 
mice in vivo. The findings have been summarized in Table 1. The suppression produced by 
the homogenates of B lymphocytes was negligible, as was that produced by glass-adherent 
cells. On the other hand the suppression produced by the homogenates of T lymphocytes was 
56 %. The homogenates of normal mouse pleen cell preparations had negligible ffect. 
Suppression mediated by SF is antigen-specific 
To study the antigenic specificity of the SF-mediated suppression spleen cell cultures were 
stimulated by different heterologous antigens and the effect of SF on their PFC counts 
examined. Table 2 presents the findings of this experiment. The SF suppressed 57% PFC 
against DV while those against JEV, Cox. B4 or SRBC were suppressed 12 to 16 %. The 
suppression of PFC against he heterologous antigens was insignificant as compared to that 
observed for the PFC against DV. 
Effect of treatment of suppressor cells with indomethaein 
Spleens were collected from virus-infected moribund mice and a single cell suspension was 
prepared. The cells were divided into two aliquots; one was treated with indomethacin and the 
other with the diluent of the indomethacin. The cells were washed three times and their 
suppressor activity was assayed in vitro by inoculating 4 × 106 to 5 × 106 ceils in the 
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Table 1. Suppressor activity of homogenates ofenriched spleen cell poputations 
PFC/2 × 106 spleen cells* 
.A 
r 
DV-infected mice cells~ Normal mice cells 
A ~k 
EnriChed spleen cell Suppression Suppression 
homogenate Number (%) Number (%) 
Macrophage-depleted$ 315 +_ 38 54 602 _+ 52 12 
Glass-adherent 625 +_ 70 8 640 + 48 6 
Non-glass-adherent 322 + 29 53 615 _+ 25 10 
T lymphocytes§ 297 _+ 56 56 620 + 39 9 
B lymphocytes§ 590 + 45 13 610 + 60 10 
Unfractionated 310 + 52 55 587 + 35 14 
No cells (control) 680 + 25 0 - 0 
* Mice given DV i.p. followed 48 h later by homogenate of 10 × 106 cells i.v. PFC against DV were counted 
on 6th and 7th days after DV inoculation. Mean value _+ S.D. presented. Percent suppression was calculated from
counts in control mice. 
t Spleen cell homogenate prepared from oribund DV-infected mice. 
$ Macrophage depleted by carbonyl iron treatment and magnet. 
§ T and B lymphocyte-enriched populations fractionated by nylon-wool column. 
Table 2. Antigenic specificity of the suppression mediated by SF 
Stimulating 
antigen SF 
DV 
Control 
Test + 
JEV 
Control 
Test + 
Cox. B4 
Control 
Test + 
SRBC 
Control 
Test + 
PFC/2 × 10 6 spleen cells* 
Suppression 
Number (%) 
776 _+ 33 0 
332 +_ 34 57 
273 +_ 29 0 
239 _+ 30 13 
376 _+ 25 0 
332 _+ 28 12 
732 + 36 0 
612 + 30 16 
* Spleen cell cultures were stimulated with the an igen at 0 h followed 24 h later with inoculation of SF in test 
cultures and diluent in control cultures. On days 3 and 4 cultures were harvested and IgM PFC against the 
stimulating antigen were counted. Percent suppression was calculated fromthat of controls of the antigen. 
DV-st imulated cultures. Fig. 1 shows that DV-pr imed cells suppressed 40% PFC against 
DV. In prel iminary experiments inoculation of normal mouse spleen cells to cultures had no 
effect on PFC counts. The suppression was abolished by pretreatment of  the cells with 
indomethacin,  thus showing that suppression is mediated through PG.  
Effect of indomethaein treatment of mice on production f SF i 
We have observed that SF is similar to PG in many properties (Chaturvedi  & Shukla, 
1981). To determine whether SF and PG are identical substances we have examined the 
product ion of  SF in mice whose capacity to produce PG was blocked by treatment with 
indomethacin.  Mice treated with indomethacin i.p. and control mice given diluent in place of  
the drug, were inoculated i.c. with DV.  When the mice were sick (days 8 to 11) the spleens 
were collected and their homogenates tested for suppressor activity in vivo. Findings 
presented in Table 3 show that the suppressor activity of  the spleen homogenate of  the 
SF-induced PG mediates immunosuppression in dengue 
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Fig. 1. Abrogation of the suppressor activity of the suppressor cells in vitro by treatment with 
indomethacin. A, DV 103 LDs0 inoculated into spleen cell cultures at 0 h followed 24 h later by 
inoculation of 4 x 106 to 5 x 106 suppressor cells treated with diluent; B, cultures inoculated with DV 
103 LDs0 followed 24 h later by inoculation of 4 x 106 to 5 x 106 suppressor cells treated with 
indomethacin; C, cultures inoculated with DV 103 LDs0. The cultures were harvested on days 3 and 4 
and IgM PFC against DV were counted. 
Table  3. Indomethacin treatment of mice has no effect on production of SF 
PFC/2 x 106 spleen cells* 
( 
Suppression 
Spleen homogenate Number (%) 
Drug-treated~ 440 +_ 24 46 
mice given DV i.c. 
Untreated mice given 430 + 25 47 
DV i.e. 
Normal mice 742 _+ 40 9 
None (control) 812 _+ 18 0 
* Mice were given DV i.p. followed 48 h later by spleen homogenate, 0-25 ml i.v. (1 : 10, w/v). PFC against 
DV were counted in the spleen on the 6th and 7th day after DV inoculation and mean value + S.D. presented. 
Percent suppression was calculated from counts in control mice. 
t Mice were treated with indomethacin, 0.3 mg i.p. 24 and 2 h before 103 LD~0 DV i.e. and then 0.1 mg i.p. 
at 48 h interval. Spleens were collected from moribund mice at 8 to 11 days post-infection. 
drug- t reated mice was similar to that  of  untreated mice. This  shows that  SF is dif ferent f rom 
PG.  
We then cons idered whether  PG induces product ion  of SF which in turn  causes 
suppression.  The direct approach  would have been to inoculate pure PG to see if it induces 
product ion  of  SF.  But pure preparat ions  were not  avai lable and we had  to draw conclus ions 
indirectly f rom the above experiment.  This showed that  the presence of  PG is not  necessary  
for the product ion  of  SF. 
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Fig. 2. Abrogation of the suppressor activity of SF by pretreatment of spleen cell cultures with 
indomethacin. A, Normal mouse spleen cell cultures inoculated with DV 103 LD50 at 0 h followed 24 h 
later by SF; B, culture cells pretreated with indomethacin inoculated with DV 103 LDs0 at 0 h followed 
24 h later by SF; C, culture cells pretreated with indomethacin inoculated with DV 103 LDs0 at 0 h; D, 
culture cells inoculated with DV 103 LD50 at 0 h. On days 3 and 4 the cultures were harvested and IgM 
PFC against DV were counted. The mean values + S.D. from replicate experiments have been 
presented. 
Fig. 3. Abrogation of the suppressor activity of SF in vivo by treatment of Swiss albino micewith 
indomethacin. A, mice given DV i.p. 103 LDso followed 48 h later by SF i.v.; B, mice given 0.3 mg 
indomethacin i.p. at 24 h and 2 h before DV i.p. 103 LDs0 and 48 h later by SF i.v. The mice were given 
further doses of 0.1 mgindomethacin i.p. at 48 h intervals; C, mice given indomethacin i.p. and DV 
i.p. as in group B; D, mice given DV i.p. On days 6 and 7 after DV the mice were killed and spleens 
were taken out and IgM PFC against DV were counted. 
Effect of SF on indomethacin-treated spleen cell cultures 
In this experiment, performed in vitro, the production of PG was blocked by treatment of 
cultures with indomethacin. The aim was to show that if the suppression was mediated 
through PG the SF should have remained ineffective in indomethacin-treated cultures. The 
SF suppressed 57% IgM PFC against DV (P < 0.001) when added to DV-stimulated 
cultures (Fig. 2). The suppressor activity of the SF was abolished (5% suppression) if the 
culture cells were pretreated with indomethacin. 
Effect of SF on indomethacin-treated miee 
The above experiment was repeated in vivo by comparing the suppressor activity of SF in 
normal mice with that in indomethacin-treated mice. The findings of this experiment, 
summarized in Fig. 3, show that suppression of PFC by SF was 47 % in untreated mice (P < 
0.001) while in mice treated with indomethacin the suppression was 5 % (P > 0-05). 
These two experiments show that in vitro as well as in vivo the SF has no suppressor 
activity by itself, but the activity is mediated through prostaglandin. 
SF stimulates normal mouse spleen cells to produce prostaglandin 
The following experiments were done to determine whether SF needs the presence of PG to 
mediate suppression or whether it also stimulates production of PG by normal mouse spleen 
cells. The mouse spleen cells, with and without prior exposure to indomethacin, were 
stimulated with SF in vitro for 1 h and then the cells were cultured for 24 h at 37 °C after 
washing three times to remove unadsorbed SF. The culture supernates collected after 24 h 
were screened for suppressor activity in vivo in mice. Data presented in Table 4 show that 
SF-indueed PG mediates immunosuppression in dengue 
Table 4. SF induces normal mouse spleen cells to produce PG 
PFC/2 × 104 spleen cells~ 
~k 
# 
Suppression 
Culture supernatant* Number (%) 
Spleen cells stimulated by SF~ 421 + 20 44 
Drug-treated spleen cells stimulated 697 + 40 7 
by SF§ 
ATS-treated spleen cells stimulated 760 _+ 38 --1 
by SFI~ 
ATS-treated spleen cells treated 766 _+ 38 -1  
with drug and then stimulated 
by SF 
Drug-treated spleen cells 744 _+ 29 1 
Untreated spleen cells (control) 752 + 29 0 
247 
* Spleen cells were cultured at 37 °C for 24 h and then cell-free culture supernatant was collected. 
t Mice were given DV i.p. followed 48 h later by 0.25 ml of culture supernatant i.v. PFC against DV were 
counted on the 6th and 7th days after DV inoculation. Percent suppression was calculated from the counts in 
control mice. 
$ 1 × 108 spleen cells were treated with 0.4 ml (1 : 10 dilution) of SF at 4 °C for 1 h. The cells were washed 
three times and then cultured. 
§ Spleen cells pretreated with 10 -6 M-indomethaein were treated with SF. 
II Spleen cells pretreated with monoclonal nti-Thy 1.2 serum and complement were treated with SF. 
supernatants of spleen cell cultures stimulated by SF suppress PFC in vivo by 44% as 
compared to that from untreated cultures. In contrast, the suppression produced by culture 
supernatants of the indomethacin-treated c lls stimulated by SF was 7% (Table 4). These 
experiments provided further evidence that SF stimulates normal spleen cells to produce 
prostaglandin tomediate suppression. 
SF stimulates T lymphoeytes toproduce prostaglandin 
Our earlier studies have shown that the suppression is mediated through T cells (Tandon et 
al., 1979 b; Chaturvedi et aI., 1981 a). Therefore, an attempt was made to determine whether 
SF stimulates T lymphocytes to produce prostaglandin. The normal mouse spleen cells were 
treated with monoclonal anti-Thy 1.2 antibody and complement which killed 40 % of spleen 
cells. The cells were washed and the above experiment was repeated. It was observed that the 
suppression was abolished by treatment with anti-Thy 1.2 antibody (Table 4) indicating that 
SF stimulates T lymphocytes toproduce PG. 
DISCUSSION 
The present study was undertaken to resolve the r lationship between the SF and the PG in 
DV-infected mice. To answer different questions we have made use of the drug indomethacin, 
a well known irreversible inhibitor of the enzyme prostaglandin synthetase (Vane, 1976) 
which has been widely used in vitro and in vivo to inhibit production of PG (Webb & 
Nowowiejski, 1977; Mattingly & Kemp, 1979; Lapp et al., 1980; Fulton & Levy, 1980). 
Indomethacin has no other known effect on lymphocyte metabolism (Webb & Nowowiejski, 
1977). We have observed that the SF is produced even when production of PG is inhibited. 
Therefore, PG is neither needed for production of SF nor is it similar to SF. The data have 
shown that SF stimulates normal spleen cells to produce PG and further that PG is produced 
by T lymphocytes (i.e. anti-Thy 1.2 antibody + complement-sensitive cells). In DVqnfected 
mice the suppressor cells are T lymphocytes (Tandon et at., 1979a, b) which supports our 
findings described here of the production of SF by T cells. 
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The present study thus demonstrates that suppression in DV-infected mice is brought 
about in two steps. In the first step, DV stimulates T cells to produce the soluble suppressor 
factor (SF). The second step involves induction of T lymphocytes by SF to produce PG or 
products of the PG synthetase pathway which finally mediate suppression. Measurement of
PG levels both in vitro and in vivo is required to confirm induction of its production by SF. 
PG of E type has been shown to inhibit effectively the immune response and production of 
lymphokines, thus mediating a feedback regulatory loop involving two types of cells (for 
review, see Waksman, 1979). A perusal of the literature reveals that among leukocytes, 
monocytes and macrophages are the main producers of PG on stimulation by various agents 
(Gemsa et al., 1978, 1980; Friedman et al., 1979), whereas there is only one report of 
involvement of lymphocytes (Webb & Osheroff, 1976). The data presented here show that T 
lymphocytes are also capable of producing PG on stimulation by SF. Inhibition of PG does 
not affect SF production and pure SF induces production of PG. Therefore, two 
subpopulations of T lymphocytes appear to be involved, one producing SF and the other 
producing PG. Further clarification of this question will need direct assay of different T 
lymphocyte subpopulations to determine which produces SF and which PG. The cooperation 
between these subpopulations is mediated through signals provided by a soluble substance, 
SF; therefore, direct cell-to-cell contact is not needed. 
We have observed that the immunosuppression mediated by SF-PG is DV antigen-specific 
as shown by suppression of PFC against DV but not those against Japanese ncephalitis or 
Coxsackie B4 viruses or sheep erythrocytes. How PG mediates suppression and why 
sometimes this is antigen-specific is not fully known. The suppressor activity of PG has been 
attributed to intracellular increase of cyclic AMP (cAMP). Novogrodsky et al. (1979) have 
suggested that PG mediates elective suppression of lymphocyte responses via increased 
intracellular cAMP. They have further suggested that selectivity depends upon: (i) nature of 
the mitogen; (ii) difference in molecular properties of cAMP-dependent protein kinases of the 
responding cell; and (iii) difference in the stage of differentiation or activation of the immune 
system. On the other hand, Mattingly et al. (1979) have shown that the release of PG is 
controlled by a mechanism different from the production of PG. Furthermore, Mattingly & 
Kemp (1979) have suggested that some antigen specificity is involved with PG-induced 
suppression as the signal for release comes from specific antigen committed cells. It has also 
been observed that the suppressor factor, produced in mice treated with GAT or GT, is 
associated with a small quantity of the antigen or their fragments. This suppressor factor 
induces a second generation of T lymphocytes (TS2) which are absolutely specific to the 
antigen which stimulated initial suppressor cells (for review, see Tada & Okumura, 1979). In 
our model the signal for production of PG comes from specific DV antigen-primed cells, 
which probably results in antigen specificity in PG-mediated immunosuppression. SF appears 
to stimulate a de novo synthesis of PG, since indomethacin completely blocked its production. 
The mechanism of SF-stimulated PG production by T lymphocytes remains to be 
investigated. 
Part of the study has been carried out with the financial assistance of the Indian Council of Medical 
Research, New Delhi. M.I.S. is grateful to Dr Abhaya Kumar for guidance. 
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